Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Verma

Showing results (521-530 of 562) with videos related to

Pageof 57
Sort By:
Translational Oncology|December 19, 2020
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activityAhmed I Younes, Hampartsoum B Barsoumian, Duygu Sezen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional AnalysisVivek Verma, Valerie K Shostrom, Weining Zhen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2021
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung CancerArya Amini, Vivek Verma, Charles B Simone, et al.
Nature Immunology|January 12, 2026
PARP inhibition generates enhanced CD8<sup>+</sup> central memory T cells by transcriptional and metabolic reprogrammingWael Traboulsi, Pankaj Gaur, Subhadip Kundu, et al.
Frontiers in Immunology|March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and MicroenvironmentHari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.
Pain|July 14, 2020
A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgiaMiranda A L van Tilburg, Marc Parisien, Richard G Boles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Clinical Lung Cancer|October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor LocationCaitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung CancerJames W Welsh, John V Heymach, Dawei Chen, et al.
Pageof 57

Showing results (521-530 of 562) with videos related to

Sort By:
Pageof 57
Translational Oncology|December 19, 2020
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activityAhmed I Younes, Hampartsoum B Barsoumian, Duygu Sezen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional AnalysisVivek Verma, Valerie K Shostrom, Weining Zhen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2021
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung CancerArya Amini, Vivek Verma, Charles B Simone, et al.
Nature Immunology|January 12, 2026
PARP inhibition generates enhanced CD8<sup>+</sup> central memory T cells by transcriptional and metabolic reprogrammingWael Traboulsi, Pankaj Gaur, Subhadip Kundu, et al.
Frontiers in Immunology|March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and MicroenvironmentHari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.
Pain|July 14, 2020
A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgiaMiranda A L van Tilburg, Marc Parisien, Richard G Boles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.
Clinical Lung Cancer|October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor LocationCaitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung CancerJames W Welsh, John V Heymach, Dawei Chen, et al.
Pageof 57